En‐Qiang Chen

2.6k total citations
128 papers, 1.8k citations indexed

About

En‐Qiang Chen is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, En‐Qiang Chen has authored 128 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 99 papers in Epidemiology, 83 papers in Hepatology and 17 papers in Surgery. Recurrent topics in En‐Qiang Chen's work include Hepatitis B Virus Studies (80 papers), Liver Disease Diagnosis and Treatment (76 papers) and Hepatitis C virus research (62 papers). En‐Qiang Chen is often cited by papers focused on Hepatitis B Virus Studies (80 papers), Liver Disease Diagnosis and Treatment (76 papers) and Hepatitis C virus research (62 papers). En‐Qiang Chen collaborates with scholars based in China, United States and Japan. En‐Qiang Chen's co-authors include Hong Tang, Hong Tang, Meng-Lan Wang, Ya-Chao Tao, Dongbo Wu, Taoyou Zhou, Lang Bai, Yonghong Wang, Lichun Wang and Hong Tang and has published in prestigious journals such as Science, Scientific Reports and Frontiers in Immunology.

In The Last Decade

En‐Qiang Chen

123 papers receiving 1.8k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
En‐Qiang Chen 1.1k 1.1k 315 234 160 128 1.8k
Gian Lodovico Rapaccini 1.1k 0.9× 910 0.9× 436 1.4× 195 0.8× 107 0.7× 51 1.9k
Eirini I. Rigopoulou 2.2k 1.9× 2.3k 2.1× 755 2.4× 334 1.4× 191 1.2× 117 3.6k
Luis A. Balart 2.7k 2.4× 2.9k 2.7× 448 1.4× 365 1.6× 148 0.9× 64 4.0k
Roger K. Moreira 624 0.5× 627 0.6× 499 1.6× 177 0.8× 81 0.5× 59 1.7k
Susanne Rasoul‐Rockenschaub 488 0.4× 486 0.5× 683 2.2× 370 1.6× 124 0.8× 56 1.9k
G. Bresci 616 0.5× 760 0.7× 432 1.4× 133 0.6× 135 0.8× 56 1.4k
L. Pagliaro 1.7k 1.5× 1.7k 1.6× 773 2.5× 150 0.6× 129 0.8× 74 2.5k
Ángela Puente 664 0.6× 511 0.5× 350 1.1× 201 0.9× 110 0.7× 77 1.6k
Toshikazu Uchida 1.2k 1.0× 1.5k 1.4× 594 1.9× 203 0.9× 184 1.1× 72 2.1k
Geri Brown 475 0.4× 458 0.4× 281 0.9× 146 0.6× 74 0.5× 48 1.3k

Countries citing papers authored by En‐Qiang Chen

Since Specialization
Citations

This map shows the geographic impact of En‐Qiang Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by En‐Qiang Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites En‐Qiang Chen more than expected).

Fields of papers citing papers by En‐Qiang Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by En‐Qiang Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by En‐Qiang Chen. The network helps show where En‐Qiang Chen may publish in the future.

Co-authorship network of co-authors of En‐Qiang Chen

This figure shows the co-authorship network connecting the top 25 collaborators of En‐Qiang Chen. A scholar is included among the top collaborators of En‐Qiang Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with En‐Qiang Chen. En‐Qiang Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Shuang, Meng Li, Jinxin Zhang, et al.. (2025). A symbiotic filamentous gut fungus ameliorates MASH via a secondary metabolite–CerS6–ceramide axis. Science. 388(6746). eadp5540–eadp5540. 4 indexed citations
2.
Jiang, Wei, Qingmin Zeng, Changhai Liu, et al.. (2025). Huc-MSCs-derived exosomes alleviate non-alcoholic steatohepatitis by regulating macrophages polarization through miR-24-3p/STING axis. Stem Cell Research & Therapy. 16(1). 74–74. 9 indexed citations
3.
Xiong, Pei, Wei Jiang, Qingmin Zeng, et al.. (2024). Mendelian‐randomization study revealed causal relationship between nonalcoholic fatty liver disease and osteoporosis/fractures. Journal of Gastroenterology and Hepatology. 39(5). 847–857. 5 indexed citations
4.
Chen, En‐Qiang, et al.. (2024). Optimal Treatment Based on Interferon No Longer Makes Clinical Cure of Chronic Hepatitis B Far Away: An Evidence‐Based Review on Emerging Clinical Data. Clinical Pharmacology & Therapeutics. 116(2). 295–303. 3 indexed citations
5.
6.
Fan, Ping, Lanqing Li, & En‐Qiang Chen. (2023). The urgency to expand the antiviral indications of general chronic hepatitis B patients. Frontiers in Medicine. 10. 1165891–1165891. 1 indexed citations
7.
He, J, Pei Xiong, Wei Jiang, et al.. (2023). Tracking of Stem Cells in Chronic Liver Diseases: Current Trends and Developments. Stem Cell Reviews and Reports. 20(2). 447–454. 2 indexed citations
8.
Li, Yujin, et al.. (2023). Antiviral Therapy Favors a Lower Risk of Liver Cirrhosis in HBeAg-negative Chronic Hepatitis B with Normal Alanine Transaminase and HBV DNA Positivity. Journal of Clinical and Translational Hepatology. 11(7). 1465–1475. 6 indexed citations
9.
Li, Lanqing, Jing Zhou, Yujing Li, et al.. (2023). Effectiveness and safety of tenofovir amibufenamide and its comparison with tenofovir alafenamide in patients with chronic hepatitis B: results from a retrospective real-world study. Frontiers in Pharmacology. 14. 1165990–1165990. 9 indexed citations
10.
Wang, Yonghong, Meng-Lan Wang, Ya-Chao Tao, et al.. (2023). The high level of IL-1β in the serum of ACLF patients induces increased IL-8 expression in hUC-MSCs and reduces the efficacy of hUC-MSCs in liver failure. Stem Cell Research & Therapy. 14(1). 231–231. 5 indexed citations
11.
Chen, En‐Qiang, et al.. (2023). Mesenchymal Stem Cell Therapy in Acute Liver Failure. Gut and Liver. 17(5). 674–683. 16 indexed citations
12.
Li, Juan, Dongbo Wu, En‐Qiang Chen, et al.. (2020). TRAIL inhibits HBV replication and expression by down-regulating liver-enriched transcription factors. Arab Journal of Gastroenterology. 21(3). 169–173. 4 indexed citations
13.
Wu, Dongbo, et al.. (2017). Propylthiouracil-induced liver failure and artificial liver support systems: a case report and review of the literature. Therapeutics and Clinical Risk Management. Volume 13. 65–68. 5 indexed citations
14.
15.
Wang, Meng-Lan, Qiaoling Zhou, En‐Qiang Chen, et al.. (2016). Low Ratio of Treg to Th17 Cells After 36 Weeks of Telbivudine Therapy Predict HBeAg Seroconversion. Viral Immunology. 29(6). 332–342. 5 indexed citations
16.
Tang, Hong, En‐Qiang Chen, Lanlan Chen, et al.. (2015). Serum hepatitis B surface antigen titer and transient elastography in screening for insignificant fibrosis in HBeAg-positive chronic hepatitis B patients. Therapeutics and Clinical Risk Management. 11. 229–229. 5 indexed citations
17.
Du, Lingyao, Yao‐Li Cui, En‐Qiang Chen, et al.. (2014). Correlation between the suppressor of cytokine signaling-1 and 3 and hepatitis B virus: possible roles in the resistance to interferon treatment. Virology Journal. 11(1). 51–51. 14 indexed citations
18.
Ma, Yuanji, et al.. (2011). Primary hepatic diffuse large B cell lymphoma: A case report. Hepatitis Monthly. 11(332). 203–205. 14 indexed citations
19.
Wang, Lichun, En‐Qiang Chen, Li-Yu Chen, et al.. (2011). Prospective Evaluation of FibroScan for the Diagnosis of Hepatic Fibrosis Compared with Liver Biopsy/AST Platelet Ratio Index and FIB-4 in Patients with Chronic HBV Infection. Digestive Diseases and Sciences. 56(9). 2742–2749. 77 indexed citations
20.
Wang, Lichun, En‐Qiang Chen, Xiaofeng Zhu, et al.. (2011). Factors Predicting the Effi cacy of Adefovir Dipivoxil on Treatment-Naïve Chronic Hepatitis B Patients at 48 Weeks. Gut and Liver. 5(4). 478–485. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gian Lodovico Rapaccini Breakdown of academic impact, for papers by Eirini I. Rigopoulou Breakdown of academic impact, for papers by Luis A. Balart Breakdown of academic impact, for papers by Roger K. Moreira Breakdown of academic impact, for papers by Susanne Rasoul‐Rockenschaub Breakdown of academic impact, for papers by G. Bresci Breakdown of academic impact, for papers by L. Pagliaro Breakdown of academic impact, for papers by Ángela Puente Breakdown of academic impact, for papers by Toshikazu Uchida Breakdown of academic impact, for papers by Geri Brown
Rankless by CCL
2026